Gilead, Cipla Ink Deal To End HIV Drug Buyers' Antitrust Suit
Gilead Sciences Inc. and generics maker Cipla told a California federal judge Friday they've reached a settlement ending a proposed class action filed by a public employees' health insurance fund over...To view the full article, register now.
Already a subscriber? Click here to view full article